Partnering with us

Akston is building deep partnerships around the world. We license our patents for commercialization and maintain close involvement with our partners throughout the development process.

We have licensed our two once-a-week veterinary insulins to Dechra Pharmaceutical PLC. We have partnered with the Helmsley Charitable Trust to develop our Human type 1 diabetes intervention. Our company also has active development programs in human once-a-week insulin and oncology.

If you are interested in speaking with us about partnering opportunities, please contact us.


Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Additional information is available at



Helmsley Charitable Trust aspires to improve lives by supporting effective organizations in health, place-based initiatives, education and human services. Since beginning active grantmaking in 2008, Helmsley has committed more than $1.8 billion for a wide range of charitable purposes. Additional information is available at


NIDDK  research creates knowledge about and treatments for diseases that are among the most chronic, costly, and consequential for patients, their families, and the Nation. Additional information is available at


QipWorks is a full-service IP strategic advisory firm that partners with technology companies, innovators, and investors to build, manage and utilize IP portfolios. The company provides extensive expertise in patent portfolio development and an intimate understanding of the rigor required at all stages of the innovation and patent lifecycle. Additional information is available at